ACHC three-lens brief
Evidence-based stock research on ACHC. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Analyst mean target $33.39 — 17% above current (14 analysts). · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Analyst mean target $33.39 — 17% above current (14 analysts).
- Negative free cash flow last quarterly (-$104.96M).
ACHC closed at $28.53 (+1.21%) as of 2026-09-11. Market cap: $2.66B. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $33.39 — 17% above current (14 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; negative free cash flow last quarterly (-$104.96M).. Last quarter: Revenue $865.84M, net income $10.93M, free cash flow -$104.96M.
Why three lenses on ACHC, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ACHCacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ACHC" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ACHC brief"></iframe>